Man Group’s Merck MRK Stock Holding History

Man Group’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$35.1M	Buy	291,400 +46,800	+19%	+$5.4M	0.06%	314
2025 Q4	$25.7M	Buy	244,600 +82,600	+51%	+$7.75M	0.04%	413
2025 Q3	$13.6M	Sell	162,000 -134,500	-45%	-$11.1M	0.02%	662
2025 Q2	$23.5M	Buy	296,500 +51,300	+21%	+$4.08M	0.04%	448
2025 Q1	$22M	Buy	245,200 +43,600	+22%	+$4.07M	0.06%	405
2024 Q4	$20.1M	Buy	201,600 +71,600	+55%	+$7.38M	0.05%	427
2024 Q3	$14.8M	Buy	130,000 +55,900	+75%	+$6.64M	0.04%	569
2024 Q2	$9.17M	Buy	74,100 +10,200	+16%	+$1.31M	0.02%	739
2024 Q1	$8.43M	Sell	63,900 -1,100	-2%	-$136K	0.02%	776
2023 Q4	$7.09M	Buy	+65,000	New	+$6.75M	0.02%	812
2023 Q3	–	Sell	-3,000	Closed	-$346K	–	2069
2023 Q2	$346K	Buy	+3,000	New	+$341K	﹤0.01%	1689
2023 Q1	–	Hold	0	–	–	–	2046

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Man Group's MRK Position: Q1 2026 in Review

Man Group reduced its Merck (MRK) stake by 57% in Q1 2026, selling an estimated $121M and leaving 793,167 shares worth $95.4M. The position accounts for 0.17% of the portfolio, ranked #129.

Man Group first reported a position in MRK in Q1 2018 and has held it in 30 quarters since. The position peaked at $260M in Q1 2021. 3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Man Group held 793,167 shares of Merck worth $95.4M as of Q1 2026.
Man Group sold 1,050,361 Merck shares in Q1 2026, an estimated $121M.
Merck made up 0.17% of Man Group's portfolio in Q1 2026, its #129 holding.
Man Group first reported a position in Merck in Q1 2018 and has held it in 30 quarters since.
Man Group's Merck position peaked at $260M in Q1 2021.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.